NCT05605587View on ClinicalTrials.gov

Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial

NARecruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

May 2, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

MEN1 Gene Mutation

Interventions

DRUG

Leflunomide 20 mg

once daily for 6 months

Trial Locations (1)

4053

RECRUITING

Unispital Basel, Basel

All Listed Sponsors

lead

University Hospital, Basel, Switzerland

OTHER